To be fair, however, the ACA does
contain some provisions to reign in costs, but without altering the
basic economic structure of the system. One of these reforms was announced the other day. Manufacturers of drugs, medical devices and
medical supplies used by Medicare and Medicaid patients will soon be required to
report all payments and gifts they make to doctors or teaching
hospitals. The data will be posted on a government-run website that
will be searchable by the name of the doctor.
The New York Times reports that
25% of doctors report receiving cash payments and two-thirds report
receiving gifts from drug and medical device manufacturers. This
includes research and consulting fees; food, travel and
entertainment; free samples (“the first bag of heroin is free”);
plus all those incidentals such as pens and tote bags with the
manufacturer's name on the side. (One doctor's son said that it
wasn't until he was eight years old that he realized not all
frisbees had the word “Merck” printed on them.) These gifts
can result in doctors prescribing expensive new drugs that are no
more effective than generics, or requiring tests and procedures that
have no real benefit to the patient.
Doctors are embedded in what
anthropologists call a gift culture, a network of reciprocal favors
in which there is no explicit agreement as to when and how the favor will be
repaid. These favors create feelings of obligation to the
benefactor, obligations that may be repaid many times over, but the lack of an explicit quid pro quo reduces awareness
of the corruption that is actually taking place.
Many years ago, social psychologist Bob Cialdini reported how a little gift can go a long way. Hare
Krishna disciples who handed out paper flowers at airports, for
example, were paid back many times over by voluntary contributions
from recipients. There are several studies showing that this works
in a medical context. For example, Orlowsky and Wateska (1992)
examined the effects on doctors of free trips to seminars in sunbelt
locations sponsored by the manufacturers of two relatively new
prescription drugs. Their data showed significant increases in
prescriptions of the two drugs in comparison to other hospitals, and
in comparison to other drugs having the same effects. Interestingly,
17 out 20 doctors in the study stated unequivocally that the free trip would not
influence their behavior.
This disclosure requirement is
certainly a step in the right direction. My
question is whether it goes far enough. Lawrence Lessig, in his new
book about political corruption, Republic Lost,
calls transparency a “reform that doesn't reform.”
Have you ever looked at one of those lists of contributors to a
political campaign? Did it help you? Most of them are people and
organizations you've never heard of. The list provides little
information about what these contributors wanted or how
they were repaid after the election.
Similar lists of medical company gifts
and payments may not be very useful to consumers. How many of
them will consult the website in advance of a visit to the doctor?
Even if they do, the fact that General Electric is on a doctor's list
of contributors only helps if you know that GE manufactures the
device that will be used to scan your internal organs. The fact that
a drug company is on the list is useless unless you have memorized
which drugs that company markets. In some cases, the absence of a
corporation from the list may be more meaningful than its presence.
This website may be useful to
researchers and investigative reporters, and this could benefit
consumers indirectly if their studies are reported by the media. The
existence of the list could also embarrass some doctors into refusing
gifts, although I wouldn't count on that, since almost all doctors
erroneously believe that gifts have no effect on their decisions.
But the real problem is that this is
only a half-baked reform. Since we know the unfortunate effects payments and gifts have, they should be banned, not reported on some
obscure government website.